Table 1. The correlation between expression of CASC9 mRNA and clinical characteristics in 89 gastric cancer specimens.
Factors | n | x ± s | F | P | |
---|---|---|---|---|---|
size (cm) | < 6.0 | 41 | 2.880 ± 1.643 | ||
≥ 6.0 | 48 | 3.762 ± 1.966 | 4.916 | 0.029* | |
site | lower | 48 | 3.656 ± 2.042 | ||
middle | 19 | 3.286 ± 1.824 | |||
upper | 16 | 2.129 ± 0.956 | 3.101 | 0.031* | |
total | 6 | 4.260 ± 0.784 | |||
Borrmann type | 1/2 | 15 | 2.063 ± 0.789 | 7.320 | 0.008* |
3/4 | 74 | 3.584 ± 1.914 | |||
Depth of invassion | T2/3 | 25 | 2.612 ± 1.270 | 6.154 | 0.015* |
T4 | 64 | 3.684 ± 1.995 | |||
infiltrating pattern | INFα/β | 34 | 2.306 ± 1.093 | 21.579 | < 0.001* |
INFγ | 55 | 4.036 ± 1.956 | |||
differentiation | Well/moderate | 31 | 2.114 ± 1.147 | 23.782 | < 0.001* |
poor | 58 | 3.979 ± 1.858 | |||
Lymphatic/venous invasion | – | 54 | 3.362 ± 2.208 | 0.004 | 0.947 |
+ | 35 | 3.389 ± 1.179 | |||
TNM Node classification (7th) | N0 (0) | 27 | 1.916 ± 1.066 | 21.219 | < 0.001* |
N1(1–2) | 23 | 3.258 ± 1.324 | |||
N2 (3–6) | 21 | 3.670 ± 1.524 | |||
N3 (≥ 7) | 18 | 5.359 ± 1.864 |
Note: *indicates the difference is significant.